Literature DB >> 32181734

Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach.

Linn Woelber1, Katharina Prieske, Werner Mendling, Barbara Schmalfeldt, Hans-Jürgen Tietz, Anna Jaeger.   

Abstract

BACKGROUND: In Germany, 17-23% of the population suffers from chronic itching of the skin; in 5-10% of cases, the female genitalia are affected, specifically, the vulva. Vulvar pruritus is thus a common symptom that often markedly impairs the affected women's quality of life.
METHODS: This review is based on pertinent publications that were retrieved by a selective search in MEDLINE/PubMed for articles on the pathogenesis, diagnosis, and treatment of vul- var pruritus. The search terms were (in German and English) "vulvärer Juckreiz," "pruritus vulvae," and "genital itch," alone and in combination with "Behandlung," "Therapie," or "treat- ment."
RESULTS: The most common cause of vulvar pruritus is vulvo- vaginal candidiasis followed by chronic dermatoses, such as lichen sclerosus and vulvar eczema. Especially in refractory cases, an invasive or preinvasive lesion such as squamous epithelial dysplasia (VIN, vulvar intraepithelial neoplasia) should be borne in mind in the differential diagnosis. Rarer causes include infection, atrophy, and vulvodynia. The essen- tial elements of treatment are topical/oral antimycotic drugs and high-potency glucocorticoids, along with consistently ap- plied, basic moisturizing care and the avoidance of potential triggering factors.
CONCLUSION: As vulvar pruritus has multiple causes, standard- ization of its diagnostic evaluation and treatment would be l efficacy and to meet the diverse needs of women who suffer from this condition.

Entities:  

Mesh:

Year:  2020        PMID: 32181734      PMCID: PMC7081372          DOI: 10.3238/arztebl.2020.0126

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  69 in total

1.  Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva.

Authors:  Anne Howard; Diane Dean; Susan Cooper; Gudula Kirtshig; Fenella Wojnarowska
Journal:  Australas J Dermatol       Date:  2004-02       Impact factor: 2.875

Review 2.  HLA antigens in lichen sclerosus et atrophicus.

Authors:  K G Purcell; L V Spencer; P M Simpson; S W Helman; J W Oldfather; J F Fowler
Journal:  Arch Dermatol       Date:  1990-08

3.  Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous--implications for pathogenesis.

Authors:  J A Carlson; R Grabowski; P Chichester; E Paunovich; J Malfetano
Journal:  Am J Dermatopathol       Date:  2000-02       Impact factor: 1.533

4.  Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).

Authors:  Werner Mendling; J Brasch; O A Cornely; I Effendy; K Friese; G Ginter-Hanselmayer; H Hof; P Mayser; I Mylonas; M Ruhnke; M Schaller; E-R Weissenbacher
Journal:  Mycoses       Date:  2015-03       Impact factor: 4.377

5.  Association of autoimmune diseases with lichen sclerosus in 532 male and female patients.

Authors:  Alexander Kreuter; Yulia Kryvosheyeva; Sarah Terras; Rose Moritz; Katrin Möllenhoff; Peter Altmeyer; Nina Scola; Thilo Gambichler
Journal:  Acta Derm Venereol       Date:  2013-03-27       Impact factor: 4.437

6.  Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.

Authors:  Noritaka Oyama; Ien Chan; Sallie M Neill; Takahiro Hamada; Andrew P South; Vesarat Wessagowit; Fenella Wojnarowska; David D'Cruz; Graham J Hughes; Martin M Black; John A McGrath
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

Review 7.  Vulvar lichen sclerosus : pathophysiology and treatment.

Authors:  Yolanda R Smith; Hope K Haefner
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403

8.  [Candida glabrata : pathogenicity and therapy update].

Authors:  H-J Tietz
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

9.  Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream.

Authors:  K L Dalziel; F Wojnarowska
Journal:  J Reprod Med       Date:  1993-01       Impact factor: 0.142

Review 10.  Why we scratch an itch: the molecules, cells and circuits of itch.

Authors:  Diana M Bautista; Sarah R Wilson; Mark A Hoon
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

View more
  4 in total

Review 1.  Early Diagnostics of Vulvar Intraepithelial Neoplasia.

Authors:  Vesna Kesić; Pedro Vieira-Baptista; Colleen K Stockdale
Journal:  Cancers (Basel)       Date:  2022-04-04       Impact factor: 6.639

Review 2.  Itch Beyond the Skin-Mucosal Itch.

Authors:  Olivia J Ly Lesslar; Peter K Smith
Journal:  Front Allergy       Date:  2021-10-28

3.  Study on the application and imaging characteristics of optical coherence tomography in vulva lesions.

Authors:  Lida Xu; Qian Ma; Shaochong Lin; Juan Ju; Shuo Feng; Zhongna Shi; Yang Bai; Junzhai Song; Junpeng Du; Baojin Wang
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

Review 4.  Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.

Authors:  Gilbert Donders; István Oszkár Sziller; Jorma Paavonen; Phillip Hay; Francesco de Seta; Jean Marc Bohbot; Jan Kotarski; Jordi Antoni Vives; Bela Szabo; Ramona Cepuliené; Werner Mendling
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.